INS and diabetes mellitus: The study participants on average seemed to have more advanced type 2 diabetes because of their longer diabetes duration, higher HbA1c level, and higher insulin requirement (0.93 and 0.94 units/kg/day in the linagliptin and empagliflozin group, respectively).